Promore Pharma AB (publ) Interim report January – March 2020
2020-05-26
Net sales amounted to MSEK 0.0 (0.5) MSEK
The operating loss for the period was 7.3 (-5.5) MSEK
Net loss was 7.0 MSEK (-5.5) MSEK, corresponding to a loss per share of SEK 0.19 (-0.27)
Cash flow from operating activities amounted to -15.0 (-4.4) MSEK
Cash and cash equivalents amounted to 45.9 (26.6) MSEK
Läs hela meddelandet på Promore Pharmas hemsida.
Läs mer..